MagicTouch - PNN

MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation

MagicTouch Receives Groundbreaking ANVISA Approval for Coronary Treatment in Brazil São Paulo (Brazil), September 17: The Brazilian health sector has just experienced a turning point with the MagicTouch Brazil Approval from ANVISA, the health surveillance national authority. Concept Medical Group, the drug-delivery technology market leader, has obtained commercial approval for its lead Sirolimus-Coated Balloon (SCB) […]

Continue Reading
Concept Medical launches MAGICAL-SV trial for small-vessel coronary treatment - PNN

Concept Medical Enrolls First Patient in MAGICAL-SV IDE Trial, Expands Coronary Program Globally

Concept Medical initiates MAGICAL-SV IDE trial in the U.S. for its sirolimus-coated balloon, with the first patient enrolled at Mount Sinai. Tampa (Florida) [USA], August 4: Concept Medical Inc., a global pioneer in drug-delivery technologies, today announced the enrollment of the first patient in the MAGICAL-SV (MAGIcTouch™ Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions […]

Continue Reading